TA 0910: Clinical Trials

1 trial of TA 0910, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow TA 0910: new trials by email Literature Review of TA 0910 trials Research Report on TA 0910

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
C-Trelin OD Tab(5mg Taltirelin Hydrate), Placebo - Spinocerebellar Degeneration
Phase 4CompletedHLB Pharmaceutical Co., Ltd.1602019-03-042023-07-24

Conditions studied

Ataxia (1)  ·  Spinocerebellar Degenerations (1)

Sponsors

HLB Pharmaceutical Co., Ltd. (1)

Countries

South Korea (1)

Top investigators

Seong-beom Koh (1)